Ascidian Therapeutics
Boston, United States· Est.
Ascidian Therapeutics is developing RNA exon editing therapies to treat genetic diseases by rewriting RNA sequences.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $50M
About
Ascidian Therapeutics is developing RNA exon editing therapies to treat genetic diseases by rewriting RNA sequences.
Genetics & GenomicsRNA Therapeutics
Funding History
1Total raised:$50M
Venture$50M